Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A

Chronic Kidney Disease (CKD): Screening

Release Date: August 2012

Recommendation Summary

Summary of Recommendation and Evidence

(What's This?)
Asymptomatic Adults

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for chronic kidney disease (CKD) in asymptomatic adults. 

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Common tests considered for CKD screening include creatinine-derived estimates of glomerular filtration rate (GFR) and urine testing for albumin. Testing for and monitoring CKD for the purposes of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.

Go to the Clinical Considerations section for suggestions for practice regarding the I statement.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

Current as of: August 2012

Internet Citation: Final Update Summary: Chronic Kidney Disease (CKD): Screening. U.S. Preventive Services Task Force. September 2016.

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857